CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused developing next generation proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Merriman Curhan Ford 5th Annual Investor Summit 2008, which is being held on September 15-16, 2008 in San Francisco, CA. Curis’ presentation will take place on Monday, September 15th at 2:45 p.m. Eastern Daylight Time (11:45 a.m. local time).
